Nintx develops a new generation of medicines leveraging biodiversity.
Nintx has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
Nintx's investors include FINEP, Pitanga Fund, MOV Investimentos, Adeste, Ecoa Capital.
Nintx is headquartered in São Paulo, Brazil.
Nintx develops a new generation of medicines leveraging biodiversity.
Nintx is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nintx — Funding & Investors." VCBacked, December 13, 2024, https://www.vcbacked.co/company/nintx. Accessed September 30, 2026.
VCBacked. (2024). Nintx — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/nintx
{{cite web |title=Nintx — Funding & Investors |url=https://www.vcbacked.co/company/nintx |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated